MXPA05006573A - Metodos para el tratamiento de dolor y dano traumatico usando benzamidas y composiciones que las contienen. - Google Patents

Metodos para el tratamiento de dolor y dano traumatico usando benzamidas y composiciones que las contienen.

Info

Publication number
MXPA05006573A
MXPA05006573A MXPA05006573A MXPA05006573A MXPA05006573A MX PA05006573 A MXPA05006573 A MX PA05006573A MX PA05006573 A MXPA05006573 A MX PA05006573A MX PA05006573 A MXPA05006573 A MX PA05006573A MX PA05006573 A MXPA05006573 A MX PA05006573A
Authority
MX
Mexico
Prior art keywords
methods
pain
benzamides
alkyl
treatment
Prior art date
Application number
MXPA05006573A
Other languages
English (en)
Inventor
Tito Serafini
Original Assignee
Renovis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovis Inc filed Critical Renovis Inc
Publication of MXPA05006573A publication Critical patent/MXPA05006573A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Abstract

Se describen metodos para el tratamiento y prevencion del dolor tal como el dolor neuropatico, y lesiones traumaticas tales como la lesion traumatica del cerebro y lesion aguda de la medula espinal, que comprende la administracion de cantidades efectivas de un compuesto benzamida de formula I: (ver formula (I)), (I) donde n es 1 o 2, R1 es un grupo seleccionado de acetilo, alquilo, amino, acilamino (NHCOR3), halo, nitro y trifluoroalquilo, R2 es alquilo saturado de 3 a 5 atomos, y R3 es alquilo de 1 a 5 atomos; se describen composiciones farmaceuticas, formas de dosificacion y metodos de administracion.
MXPA05006573A 2002-12-16 2003-12-16 Metodos para el tratamiento de dolor y dano traumatico usando benzamidas y composiciones que las contienen. MXPA05006573A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43402202P 2002-12-16 2002-12-16
US10/736,460 US20040167226A1 (en) 2002-12-16 2003-12-15 Methods for the treatment of pain and traumatic injury using benzamides and compositions containing the same
PCT/US2003/039895 WO2004060286A2 (en) 2002-12-16 2003-12-16 Methods for the treatment of pain and traumatic injury using benzamides and compositions containing the same

Publications (1)

Publication Number Publication Date
MXPA05006573A true MXPA05006573A (es) 2006-02-22

Family

ID=32717767

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05006573A MXPA05006573A (es) 2002-12-16 2003-12-16 Metodos para el tratamiento de dolor y dano traumatico usando benzamidas y composiciones que las contienen.

Country Status (7)

Country Link
US (1) US20040167226A1 (es)
EP (1) EP1581202A2 (es)
JP (1) JP2006514056A (es)
AU (1) AU2003300939A1 (es)
CA (1) CA2510042A1 (es)
MX (1) MXPA05006573A (es)
WO (1) WO2004060286A2 (es)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL145552A0 (en) 1999-03-23 2002-06-30 Univ James Cook Organ arrest, protection and preservation
SI1889198T1 (sl) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Farma-informacijski sistem
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8730031B2 (en) 2005-04-28 2014-05-20 Proteus Digital Health, Inc. Communication system using an implantable device
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
WO2007028035A2 (en) 2005-09-01 2007-03-08 Proteus Biomedical, Inc. Implantable zero-wire communications system
WO2007076875A2 (en) * 2006-01-06 2007-07-12 Aarhus Universitet Compounds acting on the serotonin transporter
AU2007243280A1 (en) * 2006-04-28 2007-11-08 Northwestern University Formulations containing pyridazine compounds for treating neuroinflammatory diseases
CN101496042A (zh) 2006-05-02 2009-07-29 普罗秋斯生物医学公司 患者定制的治疗方案
SG172630A1 (en) 2006-05-29 2011-07-28 Hibernation Therapeutics Ltd Improved tissue maintenance
US20090324748A1 (en) * 2006-07-25 2009-12-31 Hibernation Therapeutics Limited Trauma therapy
WO2008066617A2 (en) 2006-10-17 2008-06-05 Proteus Biomedical, Inc. Low voltage oscillator for medical devices
EP2083680B1 (en) 2006-10-25 2016-08-10 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US8718193B2 (en) 2006-11-20 2014-05-06 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
ES2930588T3 (es) 2007-02-01 2022-12-19 Otsuka Pharma Co Ltd Sistemas de marcador de eventos ingeribles
KR101528748B1 (ko) 2007-02-14 2015-06-15 프로테우스 디지털 헬스, 인코포레이티드 고 표면적 전극을 갖는 체내 전원
CA2717162A1 (en) 2007-03-02 2008-09-12 Hibernation Therapeutics Limited Transplants
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
EP2124725A1 (en) 2007-03-09 2009-12-02 Proteus Biomedical, Inc. In-body device having a multi-directional transmitter
US8115618B2 (en) 2007-05-24 2012-02-14 Proteus Biomedical, Inc. RFID antenna for in-body device
DK2192946T3 (da) 2007-09-25 2022-11-21 Otsuka Pharma Co Ltd Kropsintern anordning med virtuel dipol signalforstærkning
ES2840773T3 (es) 2008-03-05 2021-07-07 Otsuka Pharma Co Ltd Sistemas y marcadores de eventos ingeribles de comunicación multimodo
SG195535A1 (en) 2008-07-08 2013-12-30 Proteus Digital Health Inc Ingestible event marker data framework
US8540633B2 (en) 2008-08-13 2013-09-24 Proteus Digital Health, Inc. Identifier circuits for generating unique identifiable indicators and techniques for producing same
WO2010057049A2 (en) 2008-11-13 2010-05-20 Proteus Biomedical, Inc. Ingestible therapy activator system and method
CN102271578B (zh) 2008-12-11 2013-12-04 普罗秋斯数字健康公司 使用便携式电子内脏造影系统的胃肠功能的评估及其使用方法
US9439566B2 (en) 2008-12-15 2016-09-13 Proteus Digital Health, Inc. Re-wearable wireless device
TWI503101B (zh) 2008-12-15 2015-10-11 Proteus Digital Health Inc 與身體有關的接收器及其方法
US9659423B2 (en) 2008-12-15 2017-05-23 Proteus Digital Health, Inc. Personal authentication apparatus system and method
JP2012514799A (ja) 2009-01-06 2012-06-28 プロテウス バイオメディカル インコーポレイテッド 摂取に関連するバイオフィードバックおよび個別薬物療法の方法およびシステム
US8597186B2 (en) 2009-01-06 2013-12-03 Proteus Digital Health, Inc. Pharmaceutical dosages delivery system
US8540664B2 (en) 2009-03-25 2013-09-24 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
WO2010129288A2 (en) 2009-04-28 2010-11-11 Proteus Biomedical, Inc. Highly reliable ingestible event markers and methods for using the same
WO2010132331A2 (en) 2009-05-12 2010-11-18 Proteus Biomedical, Inc. Ingestible event markers comprising an ingestible component
EP2467707A4 (en) 2009-08-21 2014-12-17 Proteus Digital Health Inc DEVICE AND METHOD FOR MEASURING BIOLOGICAL PARAMETERS
TWI517050B (zh) 2009-11-04 2016-01-11 普羅托斯數位健康公司 供應鏈管理之系統
UA109424C2 (uk) 2009-12-02 2015-08-25 Фармацевтичний продукт, фармацевтична таблетка з електронним маркером і спосіб виготовлення фармацевтичної таблетки
MX2012008922A (es) 2010-02-01 2012-10-05 Proteus Digital Health Inc Sistema de recoleccion de datos.
AU2011237612B2 (en) 2010-04-07 2016-05-12 Otsuka Pharmaceutical Co., Ltd. Miniature ingestible device
TWI557672B (zh) 2010-05-19 2016-11-11 波提亞斯數位康健公司 用於從製造商跟蹤藥物直到患者之電腦系統及電腦實施之方法、用於確認將藥物給予患者的設備及方法、患者介面裝置
WO2012071280A2 (en) 2010-11-22 2012-05-31 Proteus Biomedical, Inc. Ingestible device with pharmaceutical product
US9439599B2 (en) 2011-03-11 2016-09-13 Proteus Digital Health, Inc. Wearable personal body associated device with various physical configurations
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
MX340001B (es) 2011-07-21 2016-06-20 Proteus Digital Health Inc Dispositivo, sistema y método de comunicación móvil.
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
EP2799537B1 (en) 2011-12-28 2021-09-22 Kyoto Prefectural Public University Corporation Normalization of culture of corneal endothelial cells
RU2015105699A (ru) 2012-07-23 2016-09-10 Протеус Диджитал Хелс, Инк. Способы получения проглатываемых маркеров событий, содержащих проглатываемый компонент
CA2884922C (en) 2012-10-01 2020-11-10 Orion Corporation N-prop-2-ynyl carboxamide derivatives and their use as trpa1 antagonists
JP5869736B2 (ja) 2012-10-18 2016-02-24 プロテウス デジタル ヘルス， インコーポレイテッド 通信デバイス用の電源において電力消失およびブロードキャスト電力を適応的に最適化するための装置、システム、および方法
TWI659994B (zh) 2013-01-29 2019-05-21 美商普羅托斯數位健康公司 高度可膨脹之聚合型薄膜及包含彼之組成物
WO2014151929A1 (en) 2013-03-15 2014-09-25 Proteus Digital Health, Inc. Personal authentication apparatus system and method
JP5941240B2 (ja) 2013-03-15 2016-06-29 プロテウス デジタル ヘルス， インコーポレイテッド 金属検出器装置、システム、および方法
EP3005281A4 (en) 2013-06-04 2017-06-28 Proteus Digital Health, Inc. System, apparatus and methods for data collection and assessing outcomes
CN105722516A (zh) 2013-07-17 2016-06-29 低温药理Kf有限公司 一种用于治疗感染、败血症和损伤的方法
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
EP3047618B1 (en) 2013-09-20 2023-11-08 Otsuka Pharmaceutical Co., Ltd. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
WO2015044722A1 (en) 2013-09-24 2015-04-02 Proteus Digital Health, Inc. Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US10813920B2 (en) 2013-11-14 2020-10-27 The Doshisha Drug for treating corneal endothelium by promoting cell proliferation or inhibiting cell damage
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
BR112019000861B1 (pt) 2016-07-22 2020-10-27 Proteus Digital Health, Inc dispositivo eletrônico
CA3041041A1 (en) 2016-10-26 2018-05-03 Proteus Digital Health, Inc. Methods for manufacturing capsules with ingestible event markers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472983A (en) * 1994-04-14 1995-12-05 Centaur Pharmaceuticals, Inc. Benzamide-containing pharmaceutical compositions

Also Published As

Publication number Publication date
AU2003300939A1 (en) 2004-07-29
AU2003300939A8 (en) 2004-07-29
EP1581202A2 (en) 2005-10-05
WO2004060286A3 (en) 2004-11-04
CA2510042A1 (en) 2004-07-22
US20040167226A1 (en) 2004-08-26
WO2004060286A2 (en) 2004-07-22
JP2006514056A (ja) 2006-04-27

Similar Documents

Publication Publication Date Title
MXPA05006573A (es) Metodos para el tratamiento de dolor y dano traumatico usando benzamidas y composiciones que las contienen.
BRPI0415167A (pt) composto de amina como ligandos de canal de ìon e usos dos mesmos
BR9612423A (pt) Composto, composição farmacêutica, e, processo para tratar um estado doentio.
CY1107850T1 (el) Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
ATE381537T1 (de) Formanilid-derivative als beta2-adrenorezeptor- agonisten
RU94044671A (ru) Применение непептидных антагонистов рецептора тахикинина
HK1094191A1 (en) Phenyl-carboxamide compounds useful for treating pain
MXPA04005156A (es) Antagonistas del receptor de adenosina a2a.
DK0583421T3 (da) Substituerede dibenzoxazepinforbindelser, lægemidler og fremgangsmåder til anvendelse
RU94044454A (ru) Ингибитор аутоимунных заболеваний
RU2004110041A (ru) Фармацевтическая композиция, содержащая габапентин или его аналог и альфа-аминоамид, и ее применение в качестве анальгетика
ES2106531T3 (es) Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso.
RU94044356A (ru) Применение 2-фенил-3-ароилбензотиофенов для увеличения экспрессии тромбомодулина для ингибирования тромботического расстройства, для увеличения активации протеина с
HUP0303203A2 (hu) Eljárás demielinizáló betegségek vagy állapotok kezelésére
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
ATE402166T1 (de) Substituierte-1-phthalazinamine als vr-1- antagonisten
KR910002775A (ko) 방향족 카복실산 아미드
TW200503673A (en) Methods for the treatment of pain and traumatic injury using benzamides and compositions containing the same
ES2059348T3 (es) Composicion farmaceutica para el tratamiento de cataratas.
UA66751C2 (en) Benzamides as medicament for treatment of neurodegenerative state, a method for the preparation thereof (variants), pharnaceutical composition for treatment of neurodegenerative states and a method for treatment
GB0504362D0 (en) Cytokine modulators
EP1480678A4 (en) TREATMENT OF OPHTHALMIC DISORDERS WITH UREA OR UREA DERIVATIVES
YU64300A (sh) Derivati 2"-deoksi higromicina
BR0306625A (pt) acetamidas e benzamidas que são úteis no tratamento de disfunção sexual
TH78137A (th) วิธีการสำหรับการรักษาความเจ็บปวดและการบาดเจ็บเป็นแผลโดยใช้เบนซาไมด์และสารผสมที่มีสารดังกล่าว

Legal Events

Date Code Title Description
FA Abandonment or withdrawal